Navigation Links
Zyngenia, Inc. Raises $10 Million in Series A Funding
Date:11/4/2009

e of Chemical Biology and the Departments of Molecular Biology and Chemistry at The Scripps Institute, La Jolla, California. Dr. Barbas is renowned for his work in peptides and proteins, antibodies and chemically programmed antibodies. He has particular expertise in novel antibody technologies and was a founder of two successful antibody platform companies, Cov-X Pharmaceuticals (acquired by Pfizer) and Prolifaron (acquired by Alexion).

Zyngenia's founding management team also includes Joseph Amprey, M.D., Ph.D., former head of MedImmune Ventures, Inc., as Chief Business Officer. Dr. Amprey joined MedImmune Ventures as the first full-time employee and helped grow the portfolio from 13 investments to 28. He led 11 deals during his time at MedImmune Ventures and served on five boards. Recently, David Hilbert, Ph.D., has been appointed the Vice President and Head of Research and Development. Dr. Hilbert formerly served as Vice President of Research at both Cellective Therapeutics and Human Genome Sciences. Dr Hilbert led Research and Development at Cellective until its acquisition by MedImmune in 2005. At Human Genome Sciences, Dr Hilbert led the transformation of the company from a genomics research company to an integrated drug development organization. His expertise in oncology, autoimmunity and antibody development enabled the first IND for the company and was pivotal in the development of ABthrax and Benlysta.

In conjunction with the Series A financing, David M. Mott, NEA General Partner, will become Chairman of the Board. Robert Garland, M.D., Partner at NEA, will also join the company's board of directors. Mr. Mott focuses on biopharmaceutical investments at NEA. He is Chairman of 3-V Biosciences, a Director of Ardelyx and Zosano Pharma, and serves on the advisory board of the Scripps Translational Science Institute. Prior to joining NEA, he was President and CEO of MedImmune, which was acquired by AstraZeneca for $15.6 billion in 20
'/>"/>

SOURCE Zyngenia, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Pearl Therapeutics Raises $15.5 Million in Private Financing
2. Enobia Pharma Raises $40.1 Million Series B Financing
3. Cardiosolutions Raises $7 Million for Spacer Technology to Mitigate Mitral Regurgitation
4. MannKind Corporation Raises $250 Million in Self Managed Registered Direct Offerings of Common Stock
5. VisEn Medical Raises $7 Million in Series B Financing
6. Thermo Fisher Scientific Reports Record Third Quarter Revenues and Adjusted EPS and Raises Full-Year Guidance
7. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
8. Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S
9. Perrigo Announces Final FDA Approval of Dexcels OTC Omeprazole; Raises Full Year Earnings Guidance
10. Anesiva Raises $45 Million in Common Stock Offering
11. Follica Raises $5.5 M To Advance New Treatment for Androgenetic Alopecia Into the Clinic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... D.C (PRWEB) September 22, 2014 FierceBiotech ... top privately held biotechnology companies of 2014. FierceBiotech ... companies before selecting this year’s winners. Those selected ... biotechnology companies in the industry. , "It's ... new group of Fierce 15 companies," said Carroll. "This ...
(Date:9/22/2014)... , Sept. 22, 2014  Spherix Incorporated (SPEX) -- an ... of intellectual property, today announced that the United States Patent ... Company in the month of September that is part of ... issued patent is: USRE45,121 , Application number: US ... Filing date: Dec 27, 2012 The listed ...
(Date:9/20/2014)... 2014 HealthTronics, Inc. , ... radiology products and services, has signed a distribution ... Clinicon Corporation for its high precision laser ... minimally invasive, mobile, surgical technology—offering more choices for ... agreement, HealthTronics will make available Clinicon’s FDA-cleared SureLase™ ...
(Date:9/19/2014)... rather than electricity, to move data would consume ... a growing concern as chips, transistor counts rise. ... circuits light emitters, modulators, and detectors ... light source for optical chips is molybdenum disulfide ... as a single, atom-thick layer. Other experimental on-chip ...
Breaking Biology Technology:FierceBiotech Announces Annual “Fierce 15” Winners of 2014 2Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 2Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 3HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 2HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 3Toward optical chips 2Toward optical chips 3
... ... work of fiction that could well be tomorrow,s scientific fact. , ... Newport Beach, Calif. (PRWEB) August 27, 2009 -- The Last Generation to ... deeply devoted to his ten year old daughter who is dying of a fatal disease. ...
... Korean scientists have succeeded in engineering the bacterium E. ... published in the journal Biotechnology and Bioengineering , ... important chemical which is traditionally created using fossil fuels. ... an important platform chemical with a wide range of ...
... , ATLANTA, Aug. 26 ... "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases ... today announced that Robert McNally, Ph.D., president and chief executive ... Renshaw 11th Annual Healthcare Conference on Thursday, September 10, 2009 ...
Cached Biology Technology:Provocative New Fiction Makes for a Fascinating, Fast Paced Read 2Pioneering research succeeds in producing industrially vital chemical through engineered bacteria 2GeoVax to Present at the Rodman & Renshaw 11th Annual Healthcare Conference 2GeoVax to Present at the Rodman & Renshaw 11th Annual Healthcare Conference 3GeoVax to Present at the Rodman & Renshaw 11th Annual Healthcare Conference 4
(Date:9/21/2014)... MA -- In recent years, new strains of bacteria ... Each year, these superbugs, including drug-resistant forms of tuberculosis ... and kill at least 23,000. Despite the urgent need ... classes of antibiotics in the past decade. , MIT ... these superbugs. Using a gene-editing system that can disable ...
(Date:9/19/2014)... today by researchers from several Harvard University labs ... experienced and aspiring researchers with the intellectual raw ... made from soft, flexible materials. , With the ... other advances in manufacturing technology, soft robotics is ... drawn from conventional rigid robot design, but working ...
(Date:9/19/2014)... Inc. (Nasdaq: NXTD and NXTDW) ("Nxt-ID" or the ... updates the "Wocket in Your Pocket" celebrity ad campaign, featuring former ... classes, Vinny Pazienza (PAZ). , ... actor Ciaran Hinds and Sons of Anarchy ... have been cast in Bleed for This . ...
Breaking Biology News(10 mins):Battling superbugs 2Battling superbugs 3Battling superbugs 4Soft robotics 'toolkit' features everything a robot-maker needs 2NXT-ID's Vinny Paz Celebrity Ad Wocket Update: Katey Sagal and Ciaran Hinds Attached to His Upcoming Movie 2NXT-ID's Vinny Paz Celebrity Ad Wocket Update: Katey Sagal and Ciaran Hinds Attached to His Upcoming Movie 3
... State College currently advises a team of researchers ... garb rather than the lab coats and khakis ... composed of such apparently iconoclastic researchers? Because all ... Corrections Center, a medium security prison in Littlerock, ...
... National Laboratories engineer, and Bruce Osborn, chief operating officer ... Popular Mechanics magazine Breakthrough Innovator Award Oct. 15 during ... City. Sponsored by Bristol-Myers Squibb, the Breakthrough Awards ... personalities behind them. The joint Sandia/SES award is among ...
... new UC Davis study says that people trying to ... more naturally. "Human beings tend to think in ... more irregular," said UC Davis,postdoctoral researcher Matthew Holland, the ... may actually do less good,for natural communities than designs ...
Cached Biology News:Inmates conduct ecological research on slow-growing mosses 2Sandia, SES win Popular Mechanics Breakthrough Innovator Award 2
Mitochondria/Cytosol Fractionation Kit Research Focus: other Storage Temperature: 4C Shipping Temperature: 4C...
... increasing age, the autofluorescent pigment lipofuscin ... cell types, including neurons. The presence ... use of fluorescence microscopy in the ... broad excitation and emission spectra, which ...
... the family of calcium binding proteins such as ... of an alpha and beta chain whereas S100B ... protein is also expressed in the antigen presenting ... and interdigitating reticulum cells in the paracortex of ...
LEAF™ Purified anti-human/mouse/rat ICOS...
Biology Products: